Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Publishes Updated Corporate Presentation; Remains Focused on Upcoming Release of Initial Mineral Resource Estimate

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company focused on developing its potential world-class Iska Iska silver-tin polymetallic property located in the Potosi Department in southern Bolivia, recently provided investors and corporate stakeholders with an overview of the company’s ongoing developments. With the company having engaged in exhaustive exploratory drilling […]

Jewelry Maker GEMXX Corp. (GEMZ) Ramps Up Production at Canadian Gold Site

Mine-to-market global jewelry producer GEMXX (OTC: GEMZ) is increasing its capacity for gold ore processing at one of the company’s Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May […]

Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer

As an advanced, pre-clinical biotechnology company specializing in cell, gene, and immunotherapy, Renovaro BioSciences (NASDAQ: RENB), formerly Enochian BioSciences Inc., aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers and to potentially treat or cure serious infectious diseases such as Human Immunodeficiency Virus (“HIV”) and Hepatitis B Virus (“HBV”) […]

SuperCom Ltd. (NASDAQ: SPCB) Announces ‘Breakthrough Performance’ with Q2 and H1 2023 Results

SuperCom (NASDAQ: SPCB), a global provider of traditional and digital identity solutions, providing advanced safety, identification, Internet of Things (“IoT”), connectivity, and security solutions to governments and private and public organizations globally, recently released its financial and operating results for the three and six months ended June 30, 2023, as well as financial highlights for […]

Alternative Products Expo: Pioneering the Counterculture Industry

Counterculture retail professionals, business executives, researchers, and industry leaders, are invited to attend Alternative Products Expo to be held in Las Vegas from September 14-16, 2023.  Dedicated to promoting creativity, the much-awaited event will be focused on eco-friendly solutions and alternative products. The Expo is set to engage audiences with a wide range of unique […]

GolfLync Inc. Innovates Again by Creating the World’s First Virtual Golf Clubs(TM)

GolfLync, the innovative social media networking platform designed exclusively for golf enthusiasts, is ushering in a new era for the golfing community with its groundbreaking feature, Virtual Golf Clubs(TM) (“VGC”). This cutting-edge addition to the app empowers golfers to connect, share experiences, and create thriving golfing communities, making GolfLync the go-to destination for passionate golfers […]

RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, which is available by prescription for the treatment of acquired blepharoptosis, or low-lying eyelid(s), in adults. UPNEEQ(R) (RVL-1201) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (FDA) for acquired […]

Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer

The announcement of a binding and exclusive letter of intent to merge, between two of the most innovative companies in their respective fields, is seen as representing a potentially transformative step in the fight against cancer. Considering Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy, that has already demonstrated […]

Electronic Servitor Publication Network Inc. (XESP) Committed to Improving Client Outcomes and Creating Shareholder Value

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using advanced data analysis and smart technology, is driving up a unique value proposition to improve client outcomes. The company’s understanding of technology, its potential and its current role in facilitating positive customer relationships and influencing business growth has earned it a significant […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Affirms Product Superiority in Its 2023 Human Oral Nicotine Study, NIC-H22-1

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released results from its 2023 human oral nicotine study NIC-H22-1. Of note was its patented DehydraTECH(TM)–nicotine tobacco-free pouch product superiority, particularly when pitted against world-leading brands ZYN(R) and on!(R). The study proved that Lexaria’s product was statistically significantly faster than the two […]

 

From Our Blog

Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Details 2025 Milestones and Strategic Priorities

January 20, 2026

Beeline Holdings (NASDAQ: BLNE),  a rapidly growing digital mortgage platform streamlining the path to homeownership, presented a series of operational and financial milestones from 2025 while setting out the company’s strategic priorities for the year ahead, according to a shareholder letter published by CEO Nick Liuzza on January 15, 2026. The letter provides investors with […]

Rotate your device 90° to view site.